Albert Einstein College of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Albert Einstein College of Medicine sits in the top decile of US sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count).
Albert Einstein College of Medicine: 175 sponsored US clinical trials, 20 recruiting.
Albert Einstein College of Medicine sponsors 175 registered US clinical trials on ClinicalTrials.gov, 20 of them currently recruiting, and 121 completed. 17 of these trials are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 5 trials.
Top-decile sponsor footprint
Albert Einstein College of Medicine ranks in the top decile of sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
121 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
175 total, page 4 of 4
Early Insulin and Development of ARDS
NCT00605696
Provider Approaches to Improved Rates of Infant Nutrition and Growth Study
NCT00643253
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
NCT01354977
Mechanisms of Hypoglycemia Associated Autonomic Failure
NCT00678145
Boosting Breastfeeding in Low-Income, Multi-ethnic Women: A Primary Care Based RCT
NCT00619632
Exploratory Study Of The ERCC-1 Gene
NCT00846482
Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy
NCT00574587
Directly Observed Hepatitis C Treatment in Methadone Clinics
NCT01442311
Cardiovascular Disease Risk Factors in Chinese American Immigrants
NCT00362128
Controlling Hypertension in Diabetes- Feasibility Study
NCT01145742
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer
NCT00950365
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
NCT00450944
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
NCT00444054
Reactive Oxygen Species in the Pathogenesis of Diabetic Complications
NCT00703989
Validation of the San Francisco Syncope Rule
NCT00300625
Mind-Body Program for Cancer Patients
NCT00179387
Natural History of Oro-pharyngeal Cancer Precursors
NCT00179361
Diabetes Dietary Study- Low Carbohydrate and Low-Fat Diets in Type 2 Diabetes
NCT00795691
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
NCT00075569
Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults
NCT00179335
Improving Diabetes Outcomes With Activity, Nutrition and Medication
NCT00179374
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
NCT00179348
The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans
NCT00179400
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
NCT00005807
Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy
NCT00004149
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 20 |
| Phase 2 | 29 |
| Phase 3 | 5 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the Albert Einstein College of Medicine pipeline
20 recruiting of 175 indexed (11% open); 121 completed (69%).
Phase mix: 17 late (III/IV) vs 49 early (I/II) (early-phase heavy).
Top condition: Chronic Pain (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Albert Einstein College of Medicine: open-pipeline peers nationwide
Peers matched on 175 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 175 trials (± recruiting share)
- Bausch & Lomb Incorporated · 174 trials · 2% recruiting
- UConn Health · 178 trials · 11% recruiting
- Baylor Research Institute · 180 trials · 17% recruiting
- Abbott · 181 trials · 0% recruiting
Sponsors near 11% open enrollment (± trial volume)
- University of Memphis · 11% recruiting · 35 trials
- Children's Mercy Hospital Kansas City · 11% recruiting · 184 trials
- Janssen Research & Development · 11% recruiting · 593 trials
- Barbara Ann Karmanos Cancer Institute · 12% recruiting · 139 trials
Related
What to do with this Albert Einstein College of Medicine page
175 registered trials is a research-attention snapshot, not an endorsement of Albert Einstein College of Medicine or any single study.
- 20 of Albert Einstein College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Pain is the condition Albert Einstein College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Albert Einstein College of Medicine pipeline card: 175 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.